© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 28, 2016
Adalimumab has the potential to serve an important role in management of chronic and refractory noninfectious uveitis and associated macular edema with low rates of serious adverse events in the long term, according to a recent report. That includes pediatric patients.
Cytomegalovirus or CMVâ€™s an etiological factor in patients with hypertensive anterior uveitis in Korea, according to a recent study.
Severe asthma persists in nonsmoking and smoking patients on currently recommended therapy despite suppressed tissue inflammation within the proximal airway wall, according to a recent report.
Noninfectious uveitis (NIU) is more prevalent among female than male adults and the number of cases increase in tandem with age, according to a recent study.
Veeral Sheth, MD: Promising Developments from the Past Year in Retina
David B. Glasser, MD: The Larger Implications of Telehealth in Ophthalmology
Inequities Continue to Exist in Ophthalmology Care